Eli Lilly and Company's Fiscal Year is From January To December.
The item "Altman-Zscore" stands at 5.71 as of 09/30/2025, the lowest value since 06/30/2023.
As of the end of Eli Lilly and Company's third quarter, the item "Altman Zscore" stands at 5.71. This represents a decrease of -9.09 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -33.88 percent compared to the value the year prior.
The 1 year change in percent is -33.88.
The 3 year change in percent is -3.07.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Altman Zscore | 486,508,953,600.00 |
![]() | AbbVie Inc - Altman Zscore | 399,570,305,024.00 |
![]() | Roche Holding AG - Altman Zscore | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Altman Zscore | 280,205,508,085.11 |
![]() | Novartis AG - Altman Zscore | 255,096,620,580.91 |